n South African Medical Journal - A first step towards transparency in pricing of medicines and scheduled substances - publication of guidelines for pharmaco-economic submissions : forum - health and finance
|Article Title||A first step towards transparency in pricing of medicines and scheduled substances - publication of guidelines for pharmaco-economic submissions : forum - health and finance|
|© Publisher:||Health and Medical Publishing Group (HMPG)|
|Journal||South African Medical Journal|
|Affiliations||1 HEXOR Pty Ltd, 2 HEXOR Pty Ltd and 3 HEXOR Pty Ltd|
|Publication Date||Jan 2014|
|Pages||10 - 11|
The National Department of Health of South Africa recently published guidelines for pharmaco-economic (PE) submissions in accordance with the Medicines and Related Substances Act (Act 101 of 1965), which came into effect on 1 April 2013. These guidelines relate to the compilation of PE submissions for evidence of cost-effectiveness of medicine or scheduled substances. The PE guidelines are a first step towards the creation of a mechanism whereby the value of medicine can be quantified in a transparent manner. The 'voluntary' nature of PE submissions speaks to the current lack of knowledge, understanding and capacity related to pharmaco-economics that exists in the private healthcare market. The current disconnect between the PE guidelines and the Medical Schemes Act should be addressed as a matter of urgency to provide a mechanism whereby guidance in terms of cost-effectiveness from a PE evaluation will be supported by guaranteed reimbursement by medical schemes.
Article metrics loading...